Baltic Atherosclerosis Conference 2021 - Servier

The first independent French pharmaceutical company
More than 20,000 workers, including almost 3,000 researchers preparing medicines for the future
25% of turnover is invested in research and development
44 new chemicals are currently being developed in the following therapeutic areas: cardiovascular disease, central nervous system and psychiatry, cancer research, diabetes and metabolism, and rheumatology
Servier is represented in 140 countries on 5 continents

servier.ee/en/homepage/

View all the participants at this expo